Calcium citrate market seen reaching $1.2 billion by 2031

A new Allied Market Research report projects the global calcium citrate market will grow from $0.8 billion in 2021 to $1.2 billion by 2031, driven by food additive demand, health awareness and pharmaceutical use. Asia-Pacific was the largest regional market in 2021 and is expected to stay the fastest-growing through 2031.

Why it matters: - Calcium citrate is gaining traction in food, supplements and pharmaceuticals, which gives the market multiple demand drivers instead of relying on one industry. - Asia-Pacific’s lead matters because the region already accounts for more than two-fifths of global revenue and is expected to set the pace for future growth. - The market’s projected 3.7% CAGR through 2031 signals steady expansion, not a sharp spike.

What happened: - Allied Market Research said the global calcium citrate market was valued at $0.8 billion in 2021 and is projected to reach $1.2 billion by 2031. - The report forecasts 3.7% CAGR growth from 2022 to 2031. - Asia-Pacific was the largest regional market in 2021, with more than two-fifths of global revenue. - Asia-Pacific is expected to remain both the largest and fastest-growing region through 2031. - The report was published June 22, 2026. - The report includes an assessment of market dynamics, emerging trends, investment opportunities, competitive landscape and strategic developments. - A sample overview is available here.

The details: - Rising use of calcium citrate as a food additive is a core growth driver. - Growing consumer interest in health and wellness products is supporting demand. - Pharmaceutical applications are expanding, especially in calcium supplements and nutritional formulations. - Preventive healthcare awareness and healthier lifestyles are expected to create additional opportunities for manufacturers. - The powder segment held nearly three-fifths of global revenue in 2021. - Powder is expected to keep the lead through 2031. - Powder is projected to post the fastest CAGR in the market at 3.8%. - Powder’s growth is tied to ease of formulation and wide use in dietary supplements and food products. - The pharmaceuticals segment held over two-fifths of market share in 2021. - Pharmaceuticals is expected to remain the dominant application segment through 2031. - Pharmaceuticals is forecast to grow at the highest CAGR of 3.9%. - Demand in that segment is being supported by calcium-based nutritional supplements and therapeutic formulations. - Other regions covered in the report include North America, Europe and LAMEA.

Between the lines: - The market’s growth profile points to a ingredients business that is being pulled by both consumer health trends and industrial use. - The strongest segments are also the most formulation-friendly, which suggests suppliers with broad manufacturing and distribution reach may be best positioned. - Asia-Pacific’s leadership reflects a mix of pharmaceutical manufacturing, food processing and rising health awareness. - The list of major players suggests a fragmented market with room for partnerships, expansions and acquisitions. - Major companies named in the report include Aditya Chemicals Ltd., Alpha Drugs, Balchem Inc., Bayer AG, Daffodil Pharmachem, Parchem Fine & Specialty Chemicals, Gadot Biochemical Industries Ltd., Nikunj Chemicals, Jungbunzlauer Suisse AG, Jost Chemical Co., Adani Pharmachem Private Limited, Krishna Chemicals, Panvo Organics Pvt. Ltd., SUCROAL and Univar Solutions Inc. - The companies are focusing on partnerships, collaborations, business expansions, acquisitions and joint ventures to strengthen market position and broaden product portfolios.

What's next: - Allied Market Research expects Asia-Pacific to keep leading the market through 2031. - Growth in preventive healthcare and food processing should keep supporting demand over the forecast period. - The report says businesses and investors can use its findings to evaluate opportunities and competitive strategy. - More information is available in the purchase options page.